Revvity Return on Tangible Equity 2012-2025 | RVTY
Current and historical return on tangible equity values for Revvity (RVTY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Revvity Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $0.24B | $-1.65B | -15.59% |
| 2025-06-30 | $0.29B | $-1.57B | -19.46% |
| 2025-03-31 | $0.29B | $-1.45B | -19.94% |
| 2024-12-31 | $0.27B | $-1.44B | -18.41% |
| 2024-09-30 | $0.25B | $-1.40B | -16.62% |
| 2024-06-30 | $0.17B | $-1.45B | -10.28% |
| 2024-03-31 | $0.15B | $-1.58B | -8.61% |
| 2023-12-31 | $0.69B | $-1.68B | -38.73% |
| 2023-09-30 | $0.74B | $-1.86B | -37.33% |
| 2023-06-30 | $0.82B | $-1.85B | -37.19% |
| 2023-03-31 | $0.96B | $-1.77B | -35.59% |
| 2022-12-31 | $0.57B | $-2.48B | -17.30% |
| 2022-09-30 | $0.63B | $-2.71B | -18.04% |
| 2022-06-30 | $0.67B | $-3.85B | -16.95% |
| 2022-03-31 | $0.74B | $-4.12B | -22.42% |
| 2021-12-31 | $0.94B | $-3.31B | -36.80% |
| 2021-09-30 | $1.13B | $-4.62B | -56.51% |
| 2021-06-30 | $1.18B | $-1.17B | -104.83% |
| 2021-03-31 | $1.07B | $-1.16B | -91.87% |
| 2020-12-31 | $0.73B | $-1.08B | -58.14% |
| 2020-09-30 | $0.41B | $-1.11B | -29.97% |
| 2020-06-30 | $0.30B | $-1.33B | -20.06% |
| 2020-03-31 | $0.23B | $-1.49B | -14.71% |
| 2019-12-31 | $0.23B | $-1.58B | -14.84% |
| 2019-09-30 | $0.23B | $-1.48B | -15.26% |
| 2019-06-30 | $0.25B | $-1.62B | -16.19% |
| 2019-03-31 | $0.25B | $-1.47B | -15.68% |
| 2018-12-31 | $0.24B | $-1.57B | -14.40% |
| 2018-09-30 | $0.13B | $-1.57B | -7.31% |
| 2018-06-30 | $0.14B | $-1.70B | -10.01% |
| 2018-03-31 | $0.28B | $-1.78B | -26.22% |
| 2017-12-31 | $0.29B | $-1.85B | -38.13% |
| 2017-09-30 | $0.40B | $-0.28B | -91.57% |
| 2017-06-30 | $0.37B | $-0.37B | -69.85% |
| 2017-03-31 | $0.23B | $-0.58B | -38.26% |
| 2016-12-31 | $0.23B | $-0.52B | -37.26% |
| 2016-09-30 | $0.24B | $-0.63B | -36.34% |
| 2016-06-30 | $0.23B | $-0.64B | -35.97% |
| 2016-03-31 | $0.22B | $-0.73B | -34.05% |
| 2015-12-31 | $0.21B | $-0.61B | -33.81% |
| 2015-09-30 | $0.18B | $-0.62B | -26.64% |
| 2015-06-30 | $0.16B | $-0.61B | -26.33% |
| 2015-03-31 | $0.16B | $-0.66B | -27.69% |
| 2014-12-31 | $0.16B | $-0.73B | -28.00% |
| 2014-09-30 | $0.19B | $-0.46B | -36.42% |
| 2014-06-30 | $0.19B | $-0.50B | -32.43% |
| 2014-03-31 | $0.17B | $-0.55B | -26.02% |
| 2013-12-31 | $0.17B | $-0.61B | -23.60% |
| 2013-09-30 | $0.08B | $-0.69B | -11.45% |
| 2013-06-30 | $0.07B | $-0.75B | -9.87% |
| 2013-03-31 | $0.08B | $-0.78B | -10.45% |
| 2012-12-31 | $0.07B | $-0.71B | -9.06% |
| 2012-09-30 | $0.00B | $-0.76B | -0.36% |
| 2012-06-30 | $0.01B | $-0.81B | -1.38% |
| 2012-03-31 | $0.01B | $-0.86B | -0.98% |
| 2011-12-31 | $0.01B | $-0.91B | -1.87% |
| 2011-09-30 | $0.39B | $-0.33B | -194.00% |
| 2011-06-30 | $0.36B | $-0.36B | -198.37% |
| 2011-03-31 | $0.39B | $-0.11B | -219.30% |
| 2010-12-31 | $0.39B | $0.00B | -182.50% |
| 2010-09-30 | $0.13B | $-0.26B | -48.25% |
| 2010-06-30 | $0.13B | $-0.34B | -45.05% |
| 2010-03-31 | $0.10B | $-0.25B | -33.74% |
| 2009-12-31 | $0.08B | $-0.23B | -27.48% |
| 2009-09-30 | $0.08B | $-0.35B | -24.84% |
| 2009-06-30 | $0.12B | $-0.31B | -39.97% |
| 2009-03-31 | $0.12B | $-0.32B | -41.96% |
| 2008-12-31 | $0.13B | $-0.28B | -45.48% |
| 2008-09-30 | $0.15B | $-0.25B | -54.38% |
| 2008-06-30 | $0.13B | $-0.27B | -57.33% |
| 2008-03-31 | $0.14B | $-0.31B | -78.97% |
| 2007-12-31 | $0.13B | $-0.26B | -126.37% |
| 2007-09-30 | $0.12B | $-0.05B | -464.76% |
| 2007-06-30 | $0.12B | $-0.08B | -3226.67% |
| 2007-03-31 | $0.11B | $-0.04B | 208.45% |
| 2006-12-31 | $0.12B | $0.06B | 115.66% |
| 2006-09-30 | $0.27B | $0.04B | 175.00% |
| 2006-06-30 | $0.27B | $0.15B | 166.20% |
| 2006-03-31 | $0.27B | $0.17B | 226.56% |
| 2005-12-31 | $0.27B | $0.25B | 359.87% |
| 2005-09-30 | $0.12B | $0.08B | 634.67% |
| 2005-06-30 | $0.11B | $-0.01B | -925.00% |
| 2005-03-31 | $0.10B | $-0.02B | -388.68% |
| 2004-12-31 | $0.10B | $0.03B | -208.70% |
| 2004-09-30 | $0.09B | $-0.04B | -107.50% |
| 2004-06-30 | $0.08B | $-0.07B | -71.87% |
| 2004-03-31 | $0.06B | $-0.10B | -49.22% |
| 2003-12-31 | $0.05B | $-0.11B | -35.02% |
| 2003-09-30 | $0.02B | $-0.15B | -12.48% |
| 2003-06-30 | $0.01B | $-0.16B | -7.37% |
| 2003-03-31 | $0.00B | $-0.18B | 1.59% |
| 2002-12-31 | $-0.15B | $-0.19B | 78.65% |
| 2002-09-30 | $-0.20B | $-0.23B | 106.28% |
| 2002-06-30 | $-0.18B | $-0.15B | 121.74% |
| 2002-03-31 | $-0.14B | $-0.20B | 98.03% |
| 2001-12-31 | $0.03B | $-0.17B | -23.20% |
| 2001-09-30 | $0.12B | $-0.06B | -87.70% |
| 2001-06-30 | $0.09B | $-0.14B | -47.47% |
| 2001-03-31 | $0.10B | $-0.21B | -65.37% |
| 2000-12-31 | $0.09B | $-0.16B | -99.73% |
| 2000-09-30 | $0.09B | $-0.29B | -133.33% |
| 2000-06-30 | $0.19B | $0.04B | -1002.67% |
| 2000-03-31 | $0.16B | $0.04B | -192.59% |
| 1999-12-31 | $0.15B | $-0.04B | -230.71% |
| 1999-09-30 | $0.14B | $-0.11B | -394.41% |
| 1999-06-30 | $0.05B | $-0.21B | 94.64% |
| 1999-03-31 | $0.08B | $0.09B | 45.44% |
| 1998-12-31 | $0.10B | $0.08B | 45.44% |
| 1998-09-30 | $0.10B | $0.26B | 38.64% |
| 1998-06-30 | $0.10B | $0.28B | 39.73% |
| 1998-03-31 | $0.06B | $0.27B | 23.51% |
| 1997-12-31 | $0.03B | $0.25B | 14.11% |
| 1997-09-30 | $0.03B | $0.23B | 11.96% |
| 1997-06-30 | $0.03B | $0.24B | 11.99% |
| 1997-03-31 | $0.06B | $0.25B | 22.83% |
| 1996-12-31 | $0.06B | $0.26B | 24.06% |
| 1996-09-30 | $0.07B | $0.26B | 26.72% |
| 1996-06-30 | $0.07B | $0.25B | 27.60% |
| 1996-03-31 | $0.07B | $0.24B | 26.02% |
| 1995-12-31 | $0.07B | $0.24B | 24.95% |
| 1995-09-30 | $0.06B | $0.23B | 19.93% |
| 1995-06-30 | $-0.01B | $0.31B | -1.99% |
| 1995-03-31 | $-0.01B | $0.30B | -2.00% |
| 1994-12-31 | $-0.01B | $0.32B | -2.02% |
| 1994-09-30 | $0.01B | $0.27B | 2.04% |
| 1994-06-30 | $0.07B | $0.31B | 23.13% |
| 1994-03-31 | $0.07B | $0.29B | 25.19% |
| 1993-12-31 | $0.06B | $0.31B | 19.93% |
| 1993-09-30 | $0.06B | $0.29B | 20.20% |
| 1993-06-30 | $0.07B | $0.29B | 22.39% |
| 1993-03-31 | $0.07B | $0.30B | 22.75% |
| 1992-12-31 | $0.09B | $0.33B | 28.92% |
| 1992-09-30 | $0.09B | $0.30B | 29.13% |
| 1992-06-30 | $0.09B | $0.29B | 29.89% |
| 1992-03-31 | $0.08B | $0.30B | 30.00% |
| 1991-12-31 | $0.08B | $0.29B | 30.97% |
| 1991-09-30 | $0.08B | $0.27B | 32.28% |
| 1991-06-30 | $0.08B | $0.25B | 32.40% |
| 1991-03-31 | $0.08B | $0.24B | 33.30% |
| 1990-12-31 | $0.07B | $0.21B | 33.26% |
| 1990-09-30 | $0.07B | $0.22B | 31.96% |
| 1990-06-30 | $0.07B | $0.23B | 29.26% |
| 1990-03-31 | $0.07B | $0.23B | 26.93% |
| 1989-12-31 | $0.07B | $0.23B | 26.41% |
| 1989-09-30 | $0.07B | $0.27B | 26.33% |
| 1989-06-30 | $0.07B | $0.27B | 26.10% |
| 1989-03-31 | $0.07B | $0.28B | 26.94% |
| 1988-12-31 | $0.07B | $0.29B | 26.85% |
| 1988-09-30 | $0.06B | $0.25B | 25.13% |
| 1988-06-30 | $0.06B | $0.25B | 25.62% |
| 1988-03-31 | $0.06B | $0.24B | 24.21% |
| 1987-12-31 | $0.06B | $0.25B | 24.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.518B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.002B | 27.77 |
| HCA Healthcare (HCA) | United States | $114.483B | 17.75 |
| CVS Health (CVS) | United States | $99.460B | 11.44 |
| Elevance Health (ELV) | United States | $75.335B | 11.24 |
| Cencora (COR) | United States | $69.692B | 21.99 |
| Natera (NTRA) | United States | $28.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.132B | 21.37 |
| Labcorp Holdings (LH) | United States | $22.980B | 17.52 |
| Viatris (VTRS) | United States | $16.793B | 6.26 |
| Medpace Holdings (MEDP) | United States | $15.268B | 37.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.244B | 0.00 |
| Solventum (SOLV) | United States | $13.550B | 13.15 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.161B | 12.07 |
| CochLear (CHEOY) | Australia | $11.774B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.312B | 17.93 |
| Sonic Healthcare (SKHHY) | Australia | $7.878B | 0.00 |
| Avantor (AVTR) | United States | $7.677B | 11.73 |
| BrightSpring Health Services (BTSG) | United States | $7.156B | 42.67 |
| HealthEquity (HQY) | United States | $6.788B | 25.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.207B | 0.00 |
| PACS (PACS) | United States | $6.058B | 36.84 |
| Bausch + Lomb (BLCO) | Canada | $6.022B | 39.53 |
| Sotera Health (SHC) | United States | $5.043B | 24.32 |
| Alignment Healthcare (ALHC) | United States | $4.352B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.012B | 18.80 |
| GeneDx Holdings (WGS) | United States | $2.436B | 42.79 |
| Organon (OGN) | United States | $2.134B | 2.25 |
| Establishment Labs Holdings (ESTA) | United States | $1.999B | 0.00 |
| Progyny (PGNY) | United States | $1.892B | 37.20 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Surgery Partners (SGRY) | United States | $1.754B | 22.60 |
| Ardent Health (ARDT) | United States | $1.280B | 4.18 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.001B | 16.36 |
| Teladoc Health (TDOC) | United States | $0.889B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.828B | 13.56 |
| Nutex Health (NUTX) | United States | $0.706B | 5.40 |
| Omada Health (OMDA) | United States | $0.675B | 0.00 |
| Embecta (EMBC) | United States | $0.643B | 3.59 |
| Sonida Senior Living (SNDA) | United States | $0.642B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.563B | 25.30 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.466B | 8.57 |
| CryoPort (CYRX) | United States | $0.437B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.409B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| So-Young (SY) | China | $0.339B | 0.00 |
| Agilon Health (AGL) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.262B | 0.00 |
| Oncology Institute (TOI) | United States | $0.257B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| LifeMD (LFMD) | United States | $0.151B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.097B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.070B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.10 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |